Дефицит пенициллина в США продлен до конца 2027 года: приоритет получат беременные

The VDH provided updated information regarding the ongoing national shortage of Benzathine Penicillin (Bicilin L-A) on Thursday. According to officials, the recovery date has been extended to the fourth quarter of 2027. Benzathine Penicillin G is the only recommended treatment for pregnant women and babies with congenital syphilis. Recommended Videos The VDH released the following statement: In response to the ongoing national shortage, VDH is currently prioritizing select groups of patients to receive Bicillin L-A® in local health department clinics to treat or prevent syphilis: Women of any age who are pregnant. Women of reproductive age (15-44) regardless of pregnancy status. Partners of pregnant women with syphilis. Patients who cannot take doxycycline or are highly unlikely to comply with an oral treatment regimen, on a case-by-case basis, and as supply allows. VDH may consider further restricting Bicillin L-A® to only pregnant patients in the future if required, based on forecasted need. Providers should continue to observe the CDC guidance to treat non-pregnant adults with alternative regimens. VDH continues to maintain a small program to deliver free injectable syphilis treatment to providers who can administer treatment and who have identified syphilis in a pregnant woman or person allergic to doxycycline. https://www.vdh.virginia.gov/.../update-on-bicillin-l-a.../